{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T13:31:52Z","timestamp":1759411912545},"reference-count":56,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2015,12,22]],"date-time":"2015-12-22T00:00:00Z","timestamp":1450742400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0145243","type":"journal-article","created":{"date-parts":[[2015,12,22]],"date-time":"2015-12-22T19:00:43Z","timestamp":1450810843000},"page":"e0145243","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":11,"title":["Protection against H5N1 Influenza Virus Induced by Matrix-M Adjuvanted Seasonal Virosomal Vaccine in Mice Requires Both Antibodies and T Cells"],"prefix":"10.1371","volume":"10","author":[{"given":"Freek","family":"Cox","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthijs","family":"Baart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeroen","family":"Huizingh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeroen","family":"Tolboom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liesbeth","family":"Dekking","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaap","family":"Goudsmit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eirikur","family":"Saeland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarina","family":"Rado\u0161evi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2015,12,22]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1128\/MMBR.56.1.152-179.1992","article-title":"Evolution and ecology of influenza A viruses","volume":"56","author":"RG Webster","year":"1992","journal-title":"Microbiol Rev"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1586\/14760584.2013.824709","article-title":"The evolving history of influenza viruses and influenza vaccines","volume":"12","author":"C Hannoun","year":"2013","journal-title":"Expert Rev Vaccines"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/nrmicro2613","article-title":"Influenza A viruses: new research developments","volume":"9","author":"RA Medina","year":"2011","journal-title":"Nat Rev Microbiol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0065-3527(09)73002-7","article-title":"Use of Animal Models to Understand the Pandemic Potential of Highly Pathogenic Avian Influenza Viruses","volume":"73","author":"Jessica A. Belser KJS","year":"2009","journal-title":"Advances in Virus Research"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2567.2006.02421.x","article-title":"Variation and infectivity neutralization in influenza","volume":"119","author":"M Knossow","year":"2006","journal-title":"Immunology"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/290713a0","article-title":"Antigenic structure of influenza virus haemagglutinin defined by hybridoma antibodies","volume":"290","author":"W Gerhard","year":"1981","journal-title":"Nature"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1126\/science.1171491","article-title":"Antibody recognition of a highly conserved influenza virus epitope","volume":"324","author":"DC Ekiert","year":"2009","journal-title":"Science"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1126\/science.1204839","article-title":"A highly conserved neutralizing epitope on group 2 influenza A viruses","volume":"333","author":"DC Ekiert","year":"2011","journal-title":"Science"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.coviro.2012.02.005","article-title":"Broadly neutralizing antibodies against influenza virus and prospects for universal therapies","volume":"2","author":"DC Ekiert","year":"2012","journal-title":"Curr Opin Virol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"e3942","DOI":"10.1371\/journal.pone.0003942","article-title":"Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells","volume":"3","author":"M Throsby","year":"2008","journal-title":"PLoS One"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1126\/science.1222908","article-title":"Highly conserved protective epitopes on influenza B viruses","volume":"337","author":"C Dreyfus","year":"2012","journal-title":"Science"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"e9106","DOI":"10.1371\/journal.pone.0009106","article-title":"New class of monoclonal antibodies against severe influenza: prophylactic and therapeutic efficacy in ferrets","volume":"5","author":"RH Friesen","year":"2010","journal-title":"PLoS One"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nm.3443","article-title":"Broadly neutralizing hemagglutinin stalk-specific antibodies require FcgammaR interactions for protection against influenza virus in vivo","volume":"20","author":"DJ DiLillo","year":"2014","journal-title":"Nat Med"},{"key":"ref14","article-title":"Cross-reactive influenza-specific antibody-dependent cellular cytotoxicity in intravenous immunoglobulin as a potential therapeutic against emerging influenza viruses","author":"S Jegaskanda","year":"2014","journal-title":"J Infect Dis"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1128\/JVI.02434-12","article-title":"Neuraminidase-inhibiting antibody is a correlate of cross-protection against lethal H5N1 influenza virus in ferrets immunized with seasonal influenza vaccine","volume":"87","author":"S Rockman","year":"2013","journal-title":"J Virol"},{"key":"ref16","article-title":"Universal Anti-Neuraminidase Antibody Inhibiting all Influenza A Subtypes","author":"TM Doyle","journal-title":"Antiviral Res"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1586\/erv.11.130","article-title":"Influenza viral neuraminidase: the forgotten antigen","volume":"10","author":"BE Johansson","year":"2011","journal-title":"Expert Rev Vaccines"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/mi.2012.69","article-title":"Natural and long-lasting cellular immune responses against influenza in the M2e-immune host","volume":"6","author":"M Schotsaert","year":"2013","journal-title":"Mucosal Immunol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.3390\/v6062465","article-title":"In the shadow of hemagglutinin: a growing interest in influenza viral neuraminidase and its role as a vaccine antigen","volume":"6","author":"TJ Wohlbold","year":"2014","journal-title":"Viruses"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"5512","DOI":"10.1128\/JVI.03030-12","article-title":"Antibody-dependent cellular cytotoxicity is associated with control of pandemic H1N1 influenza virus infection of macaques","volume":"87","author":"S Jegaskanda","year":"2013","journal-title":"J Virol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.virol.2008.11.035","article-title":"Characterizations of four monoclonal antibodies against M2 protein ectodomain of influenza A virus","volume":"385","author":"TM Fu","year":"2009","journal-title":"Virology"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.4049\/jimmunol.0902147","article-title":"Universal vaccine based on ectodomain of matrix protein 2 of influenza A: Fc receptors and alveolar macrophages mediate protection","volume":"186","author":"K El Bakkouri","year":"2011","journal-title":"J Immunol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1016\/S0264-410X(03)00073-2","article-title":"The influenza vaccine licensing process","volume":"21","author":"JM Wood","year":"2003","journal-title":"Vaccine"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1086\/589862","article-title":"Vaccines: correlates of vaccine-induced immunity","volume":"47","author":"SA Plotkin","year":"2008","journal-title":"Clin Infect Dis"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"954602","DOI":"10.1155\/2011\/954602","article-title":"Cytotoxic CD4 T cells in antiviral immunity","volume":"2011","author":"NB Marshall","year":"2011","journal-title":"J Biomed Biotechnol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.immuni.2013.09.013","article-title":"Lung Airway-Surveilling CXCR3(hi) Memory CD8(+) T Cells Are Critical for Protection against Influenza A Virus","volume":"39","author":"B Slutter","year":"2014","journal-title":"Immunity"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.4161\/hv.26511","article-title":"Immunization with cross-conserved H1N1 influenza CD4+ T-cell epitopes lowers viral burden in HLA DR3 transgenic mice","volume":"9","author":"L Moise","year":"2013","journal-title":"Hum Vaccin Immunother"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1084\/jem.175.4.1143","article-title":"Transgenic mice lacking class I major histocompatibility complex-restricted T cells have delayed viral clearance and increased mortality after influenza virus challenge","volume":"175","author":"BS Bender","year":"1992","journal-title":"J Exp Med"},{"key":"ref29","article-title":"Virus-specific T cells as correlate of (cross)-protective immunity against influenza","author":"AF Altenburg","year":"2014","journal-title":"Vaccine"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1128\/JVI.01812-10","article-title":"T cell-mediated protection against lethal 2009 pandemic H1N1 influenza virus infection in a mouse model","volume":"85","author":"H Guo","year":"2011","journal-title":"J Virol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1086\/515285","article-title":"Heterotypic protection against influenza by immunostimulating complexes is associated with the induction of cross-reactive cytotoxic T lymphocytes","volume":"177","author":"S Sambhara","year":"1998","journal-title":"J Infect Dis"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1006\/cimm.2001.1835","article-title":"Heterosubtypic immunity against human influenza A viruses, including recently emerged avian H5 and H9 viruses, induced by FLU-ISCOM vaccine in mice requires both cytotoxic T-lymphocyte and macrophage function","volume":"211","author":"S Sambhara","year":"2001","journal-title":"Cell Immunol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1038\/nbt.2436","article-title":"Protective efficacy of in vitro synthesized, specific mRNA vaccines against influenza A virus infection","volume":"30","author":"B Petsch","year":"2012","journal-title":"Nat Biotechnol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"e1003207","DOI":"10.1371\/journal.ppat.1003207","article-title":"Cooperativity between CD8+ T cells, non-neutralizing antibodies, and alveolar macrophages is important for heterosubtypic influenza virus immunity","volume":"9","author":"BJ Laidlaw","year":"2013","journal-title":"PLoS Pathog"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.vaccine.2014.11.054","article-title":"Virus-specific T cells as correlate of (cross-)protective immunity against influenza","volume":"33","author":"AF Altenburg","year":"2015","journal-title":"Vaccine"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"e0135723","DOI":"10.1371\/journal.pone.0135723","article-title":"Matrix-M Adjuvated Seasonal Virosomal Influenza Vaccine Induces Partial Protection in Mice and Ferrets against Avian H5 and H7 Challenge","volume":"10","author":"F Cox","year":"2015","journal-title":"PLoS One"},{"key":"ref37","article-title":"Protection against H5N1 by multiple immunizations with seasonal influenza vaccine in mice is correlated with H5 cross-reactive antibodies","author":"A Roos","year":"2015","journal-title":"Vaccine"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.4049\/jimmunol.1201574","article-title":"Cross-reactive influenza-specific antibody-dependent cellular cytotoxicity antibodies in the absence of neutralizing antibodies","volume":"190","author":"S Jegaskanda","year":"2013","journal-title":"J Immunol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"7381","DOI":"10.4049\/jimmunol.166.12.7381","article-title":"Fc receptor-mediated phagocytosis makes a significant contribution to clearance of influenza virus infections","volume":"166","author":"VC Huber","year":"2001","journal-title":"J Immunol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jim.2014.07.010","article-title":"Development of a robust reporter-based ADCC assay with frozen, thaw-and-use cells to measure Fc effector function of therapeutic antibodies","volume":"414","author":"ZJ Cheng","year":"2014","journal-title":"J Immunol Methods"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.vaccine.2008.09.092","article-title":"In vitro evidence that commercial influenza vaccines are not similar in their ability to activate human T cell responses","volume":"27","author":"MD Co","year":"2009","journal-title":"Vaccine"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.1016\/j.vaccine.2008.04.071","article-title":"Antibody and T-cell responses to a virosomal adjuvanted H9N2 avian influenza vaccine: impact of distinct additional adjuvants","volume":"26","author":"K Radosevic","year":"2008","journal-title":"Vaccine"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/j.1750-2659.2011.00256.x","article-title":"Matrix-M adjuvanted virosomal H5N1 vaccine confers protection against lethal viral challenge in a murine model","volume":"5","author":"G Pedersen","year":"2011","journal-title":"Influenza Other Respi Viruses"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1093\/infdis\/jis330","article-title":"T-helper 1 cells elicited by H5N1 vaccination predict seroprotection","volume":"206","author":"GK Pedersen","year":"2012","journal-title":"J Infect Dis"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"8049","DOI":"10.1016\/j.vaccine.2011.08.042","article-title":"Evaluation of a virosomal H5N1 vaccine formulated with Matrix M adjuvant in a phase I clinical trial","volume":"29","author":"RJ Cox","year":"2011","journal-title":"Vaccine"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"6667","DOI":"10.4049\/jimmunol.1004022","article-title":"Cutting edge: IL-15-independent maintenance of mucosally generated memory CD8 T cells","volume":"186","author":"KC Verbist","year":"2011","journal-title":"J Immunol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.virusres.2004.02.025","article-title":"Immunogenicity and protective efficacy of influenza vaccination","volume":"103","author":"C Hannoun","year":"2004","journal-title":"Virus Res"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1371\/journal.pmed.0040059","article-title":"Cross-reactive neuraminidase antibodies afford partial protection against H5N1 in mice and are present in unexposed humans","volume":"4","author":"MR Sandbulte","year":"2007","journal-title":"PLoS Med"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.copbio.2007.11.002","article-title":"Influenza virus-specific cytotoxic T lymphocytes: a correlate of protection and a basis for vaccine development","volume":"18","author":"GF Rimmelzwaan","year":"2007","journal-title":"Curr Opin Biotechnol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1099\/vir.0.029777-0","article-title":"Endogenously expressed matrix protein M1 and nucleoprotein of influenza A are efficiently presented by class I and class II major histocompatibility complexes","volume":"92","author":"JD Doucet","year":"2011","journal-title":"J Gen Virol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.4049\/jimmunol.152.4.1653","article-title":"Heterosubtypic immunity to influenza type A virus in mice. Effector mechanisms and their longevity","volume":"152","author":"S Liang","year":"1994","journal-title":"J Immunol"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/nm.2612","article-title":"Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans","volume":"18","author":"TM Wilkinson","year":"2012","journal-title":"Nat Med"},{"key":"ref53","article-title":"Cellular immune correlates of protection against symptomatic pandemic influenza","author":"S Sridhar","year":"2013","journal-title":"Nat Med"},{"issue":"Suppl 5","key":"ref54","doi-asserted-by":"crossref","first-page":"B17","DOI":"10.1016\/S0264-410X(02)00512-1","article-title":"Inflexal V a trivalent virosome subunit influenza vaccine: production","volume":"20","author":"R Mischler","year":"2002","journal-title":"Vaccine"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1750-2659.2007.00016.x","article-title":"A sensitive retroviral pseudotype assay for influenza H5N1-neutralizing antibodies","volume":"1","author":"NJ Temperton","year":"2007","journal-title":"Influenza Other Respir Viruses"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"5998","DOI":"10.1016\/j.vaccine.2009.07.079","article-title":"Pseudoparticle neutralization is a reliable assay to measure immunity and cross-reactivity to H5N1 influenza viruses","volume":"27","author":"I Alberini","year":"2009","journal-title":"Vaccine"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0145243","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T07:51:56Z","timestamp":1692172316000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0145243"}},"subtitle":[],"editor":[{"given":"Florian","family":"Krammer","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2015,12,22]]},"references-count":56,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2015,12,22]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0145243","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,22]]}}}